Tag Archives: Khiron Life Sciences Corp.

Medical Cannabis Symposium

Khiron Life Sciences Corp. to host first international medical cannabis symposium

Khiron Life Sciences Corp. to host first international medical cannabis symposium

TORONTO, Ontario, Jan. 24, 2018 /Weed Wire/ – Khiron Life Sciences Corp., a Canadian integrated medical cannabis company with its core operations in Colombia, will welcome Colombia’s medical community as co-host of the inaugural International Medical Cannabis Symposium taking place Feb. 15 in Bogotá, Colombia.

Medical Cannabis Symposium

Khiron First Company to be Fully Licensed for High and Low THC Medical Cannabis in Colombia

TORONTO, Ontario, Oct. 23, 2017 /Weed Wire/ — Khiron Life Sciences Corp. reports that further to its press release dated September 26, 2017, the Company’s wholly owned subsidiary, Khiron Colombia SAS, has been granted all the licences required for the cultivation, production, domestic distribution and international export of both low and high tetrahydrocannabinol (“THC”) medical cannabis in the country of Colombia.

Medical Cannabis Symposium

Khiron Appoints Former DEA Chief of Pharmaceutical Investigations to Advisory Board

ORONTO, Ontario, Sept. 29, 2017 /Weed Wire/ — Khiron Life Sciences Corp. (“Khiron” or the “Company”) reports the appointment of Mr. Matthew Murphy, the former U.S. Drug Enforcement Administration (“DEA”) Chief of Pharmaceutical Investigations, to the Advisory Board of the Company.

Medical Cannabis Symposium

Khiron First Company to Receive Licence for Cultivation of Medical Cannabis in Colombia

TORONTO, Ontario, Sept. 26, 2017 /Weed Wire/ — Khiron Life Sciences Corp. (“Khiron” or the “Company”) reports that its wholly owned subsidiary, Khiron Colombia SAS, has been granted the first licence ever issued by the Ministry of Justice for the cultivation of medical cannabis in Colombia.


Top